| 2024-05-10 | Sale | IO Biotech, Inc. IOBT | 10 percent owner | 658,809 0.8518% | $1.22 | $802,495 | -15.33% | |
| 2024-03-21 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 465,021 1.1289% | $0.75 | $350,951 | -4.38% | |
| 2024-03-20 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 359,979 0.8709% | $0.73 | $264,081 | -3.14% | |
| 2024-03-19 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 593,000 1.4693% | $0.76 | $447,715 | -3.45% | |
| 2024-03-18 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 842,020 2.0939% | $0.77 | $647,008 | -4.72% | |
| 2024-03-14 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 1.91M 0.8272% | $0.89 | $1.7M | -13.53% | |
| 2024-02-09 | Sale | IO Biotech, Inc. IOBT | 10 percent owner | 658,809 0.8023% | $1.50 | $988,411 | -7.36% | |
| 2023-08-09 | IO Biotech, Inc. IOBT | 10 percent owner | 2.47M 9.534% | $2.02 | $5M | -17.22% | ||
| 2023-06-23 | Sale | Reneo Pharmaceuticals, Inc. RPHM | 10 percent owner | 100,000 0.4021% | $7.10 | $709,740 | -74.33% | |
| 2023-02-16 | Spruce Biosciences, Inc. SPRB | 10 percent owner | 2.21M 0.0087% | $3.17 | $7M | -11.16% | ||
| 2022-09-14 | Edgewise Therapeutics, Inc. EWTX | 10 percent owner | 484,496 0.9211% | $10.32 | $5M | -14.66% | ||
| 2022-02-08 | Arcellx, Inc. ACLX | 10 percent owner | 1.67M 6.7728% | $15.00 | $25M | +6.58% | ||
| 2021-11-09 | IO Biotech, Inc. IOBT | 10 percent owner | 325,000 7.8787% | $14.00 | $4.55M | -62.27% | ||
| 2021-06-21 | Verve Therapeutics, Inc. VERV | 10 percent owner | 700,000 4.5226% | $19.00 | $13.3M | -7.41% | ||
| 2021-06-02 | Sale | Inogen, Inc. INGN | 10 percent owner | 680,000 2.9808% | $57.32 | $38.98M | -41.64% | |
| 2021-05-19 | Sale | Spruce Biosciences, Inc. SPRB | 10 percent owner | 475,000 1.8365% | $13.90 | $6.6M | -71.54% | |
| 2021-04-13 | Reneo Pharmaceuticals, Inc. RPHM | 10 percent owner | 666,666 3.8272% | $15.00 | $10M | -34.38% | ||
| 2021-03-30 | Edgewise Therapeutics, Inc. EWTX | 10 percent owner | 1.25M 1.3005% | $16.00 | $20M | -42.5% | ||
| 2021-03-01 | Sale | Inogen, Inc. INGN | 10 percent owner | 790,000 3.2841% | $49.00 | $38.71M | -7.32% | |
| 2021-01-28 | Sale | Inozyme Pharma, Inc. INZY | 10 percent owner | 375,000 1.469% | $21.00 | $7.88M | -30.07% |